Target intelligence / Profile preview

Hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4) and Hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2) (HCN4 and HCN2)

Target
HCN4 and HCN2
Molecular classification
Ion channel, Nonselective cation channel, Voltage-gated ion channel
01

Overview

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are a family of nonselective voltage-gated cation channels expressed in the heart and nervous system. Among four known isoforms (HCN1–4), HCN4 is the dominant cardiac pacemaker isoform, generating the I_f (\"funny\") current that controls the spontaneous electrical activity of the sinoatrial node, and thus, heart rhythm[1][2][3]. HCN2 is highly expressed in both heart and brain, involved in rhythm generation and modulation of excitability[1][2][3][4]. Both channels are activated by hyperpolarization and modulated by cyclic nucleotides (mainly cAMP). Mutations in HCN4 are causative for certain conduction diseases, and both isoforms are targets for therapeutics aimed at heart rate and pain modulation. The channels are tetrameric, each subunit containing six transmembrane domains and an intracellular cyclic nucleotide-binding domain[1][9].

Other names
Hyperpolarization-activated cyclic nucleotide-gated channel 4Hyperpolarization-activated cation channel HCN4Pacemaker channelHyperpolarization-activated cyclic nucleotide-gated channel 2Hyperpolarization-activated cation channel HCN2
02

Mechanism of action

Blockade or inhibition of the pacemaker (\"funny,\" I_f or I_h) current in cardiac tissue (for ivabradine)\nInhibition reduces heart rate by slowing diastolic depolarization in sinoatrial node cells

03

Biological functions

Regulation of cardiac pacemaker activity (mainly HCN4)Regulation of neuronal excitability and rhythmicity (both HCN2 and HCN4)Control of membrane potential and cell excitability
04

Disease associations

Arrhythmias and cardiac conduction disorders (mainly HCN4)Neuropathic and inflammatory pain (HCN2)Neuropsychiatric and neurodegenerative disorders (both isoforms, to a lesser extent)
05

Safety considerations

Risk of bradycardia (slow heart rate) with excessive inhibitionOff-target or nonselective inhibition can affect both cardiac and neuronal functionArrhythmogenic risk in susceptible individuals
06

Interacting drugs

Ivabradine (inhibits HCN channels, especially HCN4)
07

Biomarkers

Genetic alterations (mutations) in HCN4 as markers for familial bradycardia and conduction diseasePotential for HCN4 mRNA/protein expression as a tissue biomarker for pacemaker cells

Beyond the preview

Go deeper on Hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4) and Hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2) (HCN4 and HCN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4) and Hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2) (HCN4 and HCN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call